Literature DB >> 16534157

Cardiovascular involvement in systemic lupus erythematosus: an autopsy study of 27 patients in India.

L Panchal1, S Divate, P Vaideeswar, S P Pandit.   

Abstract

BACKGROUND: Although cardiovascular disease (CVD) is recognized as a leading cause of death in patients with systemic lupus erythematosus (SLE) in western countries, there is hardly any data regarding Indian subjects with SLE. AIMS: To determine the incidence of cardiac abnormalities and vascular lesions at autopsy and to assess their contribution to the mortality in patients with SLE. SETTINGS AND
DESIGN: Retrospective retrieval of reports of autopsies performed on 35 patients with SLE over a 11 year period and analysis of 27 cases with cardiac and/or vascular lesions.
MATERIALS AND METHODS: Gross and microscopic features in 27 autopsies were analyzed with special attention to the heart and the vasculature of all organs. Findings were correlated with clinical features and ante-mortem investigations. Their contribution towards mortality was assessed.
RESULTS: Valvar lesions were the commonest cardiac lesions noted with non-bacterial thrombotic endocarditis in nine (33.33%), valvar thickening in two (7.41%), Libman-Sacks endocarditis and infective endocarditis in one (3.70%) each. Myocarditis and myocardial scarring were seen in 10 (37.03%) and seven (25.92%) cases, respectively. Fibrinous pericarditis was noted in seven (25.92%). Thromboses/embolism, vasculitis and severe coronary atherosclerosis were seen in nine (33.33%), five (18.52%) and one (3.70%) subjects, respectively. Renal disease [13, 48.14%] and cardiovascular manifestations [8, 29.62%] were the leading causes of death in our patient population.
CONCLUSION: CVD contributes significantly to the mortality in patients with SLE in India. It is second only to renal disease in this regard.

Entities:  

Mesh:

Year:  2006        PMID: 16534157

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN: 0022-3859            Impact factor:   1.476


  7 in total

1.  The role of first-pass perfusion deficit in the detection of cardiac subendocardial manifestation in patients with autoimmune vasculitis.

Authors:  Alexander Pfeil; Gabriele Lehmann; Joachim Böttcher; Gunter Wolf; Andreas Hansch
Journal:  Rheumatol Int       Date:  2012-01-03       Impact factor: 2.631

2.  Case of severe acute lupus myocarditis and multiple-organ failure.

Authors:  Aaron M Hawkins; Lalith S B Jesuthasan; Deepak L Vardesh
Journal:  BMJ Case Rep       Date:  2018-06-19

3.  Non-infectious lupus pericarditis: a retrospective hospital-based observation in Yaoundé-Cameroon.

Authors:  Madeleine Singwe Ngandeu; Pierre Ndobo; Cem Gabay
Journal:  Clin Rheumatol       Date:  2009-01-17       Impact factor: 2.980

4.  Cardiovascular complications of systemic lupus erythematosus: impact of risk factors and therapeutic efficacy-a tertiary centre experience in an Appalachian state.

Authors:  Elise Danielle McVeigh; Amna Batool; Arnold Stromberg; Ahmed Abdel-Latif; Nayef Mohammed Kazzaz
Journal:  Lupus Sci Med       Date:  2021-05

5.  Utility of cardiac MRI for diagnosis and post-treatment follow-up of lupus myocarditis.

Authors:  Farhood Saremi; Oganes Ashikyan; Rajeev Saggar; John Vu; Molly E Nunez
Journal:  Int J Cardiovasc Imaging       Date:  2006-09-28       Impact factor: 2.316

6.  Anti-nuclear antibodies positive serum from systemic lupus erythematosus patients promotes cardiovascular manifestations and the presence of human antibody in the brain.

Authors:  Marie Kelly-Worden; Leslie Hammer; Robyn Gebhard; Lauran Schrader; Marley Griffin; Dalahnna Cooper
Journal:  J Pharm Bioallied Sci       Date:  2014-07

7.  The heart in systemic lupus erythematosus - A comprehensive approach by cardiovascular magnetic resonance tomography.

Authors:  Thilo Burkard; Marten Trendelenburg; Thomas Daikeler; Christoph Hess; Jens Bremerich; Philip Haaf; Peter Buser; Michael J Zellweger
Journal:  PLoS One       Date:  2018-10-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.